• 1. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 2. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 3. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 4. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 5. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines N-acylpiperidines

Introduction to 2,2-Dimethyl-3-(piperidin-1-ylcarbonyl)-cyclopropanecarboxylic acid (CAS No. 1142215-00-6)

2,2-Dimethyl-3-(piperidin-1-ylcarbonyl)-cyclopropanecarboxylic acid, identified by its CAS number 1142215-00-6, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to a class of molecules characterized by a cyclopropane ring incorporated with functional groups that enhance its biological activity. The presence of a piperidine moiety and a carbonyl group at the 3-position of the cyclopropane ring contributes to its unique chemical properties and potential applications in drug development.

The cyclopropane ring is a key structural feature in this compound, known for its high reactivity and ability to engage in various chemical transformations. This structural motif has been widely explored in medicinal chemistry due to its ability to modulate enzyme activity and interact with biological targets. The 2,2-dimethyl substitution on the cyclopropane ring further stabilizes the molecule while maintaining its reactivity, making it a versatile scaffold for synthetic modifications.

The piperidin-1-ylcarbonyl group is another critical component of this compound, which not only influences its solubility and metabolic stability but also provides a site for further derivatization. Piperidine derivatives are well-documented for their role in enhancing drug-like properties such as bioavailability and binding affinity. The combination of these features makes 2,2-Dimethyl-3-(piperidin-1-ylcarbonyl)-cyclopropanecarboxylic acid a promising candidate for the development of novel therapeutic agents.

In recent years, there has been growing interest in the use of cyclopropane-containing compounds in drug discovery. These molecules have been shown to exhibit potent activity against various biological targets, including enzymes and receptors involved in inflammatory pathways. For instance, studies have demonstrated that cyclopropane derivatives can inhibit the activity of cyclooxygenase (COX) enzymes, which are key players in the synthesis of prostaglandins and play a crucial role in pain and inflammation.

Additionally, the piperidin-1-ylcarbonyl group in this compound suggests potential applications in the development of protease inhibitors. Proteases are enzymes that play essential roles in many biological processes, including signal transduction and protein turnover. By targeting specific proteases, it may be possible to develop treatments for conditions such as cancer, infectious diseases, and autoimmune disorders. The structural flexibility offered by the cyclopropane ring allows for precise tuning of binding interactions with target proteins, making this compound a valuable tool in rational drug design.

Recent advancements in computational chemistry have further enhanced the understanding of how 2,2-Dimethyl-3-(piperidin-1-ylcarbonyl)-cyclopropanecarboxylic acid interacts with biological targets. Molecular docking studies have revealed that this compound can bind effectively to active sites of enzymes such as COX and proteases, suggesting its potential as a lead compound for drug development. These studies also highlight the importance of optimizing the substitution pattern on the cyclopropane ring to improve binding affinity and selectivity.

The synthesis of 2,2-Dimethyl-3-(piperidin-1-ylcarbonyl)-cyclopropanecarboxylic acid involves multi-step organic reactions that require careful control of reaction conditions to ensure high yield and purity. The introduction of the piperidine moiety typically involves nucleophilic substitution reactions, while the carbonyl group is often introduced via condensation reactions or oxidation processes. Advanced synthetic techniques such as transition metal-catalyzed cross-coupling reactions have been employed to streamline the synthesis and improve scalability.

In conclusion, 2,2-Dimethyl-3-(piperidin-1-ylcarbonyl)-cyclopropanecarboxylic acid (CAS No. 1142215-00-6) represents a significant advancement in pharmaceutical chemistry due to its unique structural features and potential applications in drug development. The combination of a reactive cyclopropane ring and a functional piperidine moiety makes this compound a versatile scaffold for designing novel therapeutic agents. As research continues to uncover new biological targets and synthetic strategies, compounds like 2,2-Dimethyl-3-(piperidin-1-ylcarbonyl)-cyclopropanecarboxylic acid are poised to play a crucial role in addressing unmet medical needs.

• 915924-95-7(1-Isobutyl-6-oxopiperidine-3-carboxylic acid)
• 169253-07-0(2-(1-acetylpiperidin-3-yl)acetic acid)
• 2637-76-5(1-Acetylpiperidine-3-carboxylic acid)
• 700815-60-7(1-(cyclobutylcarbonyl)piperidine-4-carboxylic Acid)
• 25503-90-6(1-Acetylpiperidine-4-carboxylic acid)
• 923177-08-6(1-(2,2-DIMETHYLPROPANOYL)PIPERIDINE-3-CARBOXYLIC ACID)
• 330985-26-7(1-Isobutyryl-4-piperidinecarboxylic Acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)